On the public citation graph

Non‐small cell lung cancer in China

0 signed · 955 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2013.284692openalex-snapshot
Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012
inferredcites →https://doi.org/10.1001/jama.2014.3741openalex-snapshot
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
inferredcites →https://doi.org/10.1001/jama.2019.3241openalex-snapshot
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
inferredcites →https://doi.org/10.1001/jamainternmed.2013.12738openalex-snapshot
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
inferredcites →https://doi.org/10.1001/jamainternmed.2018.3056openalex-snapshot
Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening
inferredcites →https://doi.org/10.1001/jamaoncol.2016.5945openalex-snapshot
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
inferredcites →https://doi.org/10.1001/jamaoncol.2016.6416openalex-snapshot
Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015
inferredcites →https://doi.org/10.1001/jamaoncol.2018.3039openalex-snapshot
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2021.0366openalex-snapshot
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2021.2301openalex-snapshot
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2021.3523openalex-snapshot
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2021.4761openalex-snapshot
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1002/cac2.12099openalex-snapshot
The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017
inferredcites →https://doi.org/10.1002/cac2.12153openalex-snapshot
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
inferredcites →https://doi.org/10.1002/cac2.12225openalex-snapshot
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
inferredcites →https://doi.org/10.1002/cac2.12227openalex-snapshot
Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy
inferredcites →https://doi.org/10.1002/cac2.12359openalex-snapshot
Non‐small cell lung cancer in China
inferredcites →https://doi.org/10.1002/cam4.2183openalex-snapshot
Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
inferredcites →https://doi.org/10.1002/cncr.27940openalex-snapshot
KIF5B‐RET fusions in Chinese patients with non–small cell lung cancer
inferredcites →https://doi.org/10.1002/cncy.21286openalex-snapshot
The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma
inferredcites →https://doi.org/10.1002/ijc.29020openalex-snapshot
Home kitchen ventilation, cooking fuels, and lung cancer risk in a prospective cohort of never smoking women in S hanghai, C hina
inferredcites →https://doi.org/10.1002/ijc.30447openalex-snapshot
Estimation of heritability for nine common cancers using data from genome‐wide association studies in Chinese population
inferredcites →https://doi.org/10.1002/ijc.30806openalex-snapshot
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
inferredcites →https://doi.org/10.1002/ijc.32033openalex-snapshot
Is high vitamin B12 status a cause of lung cancer?
inferredcites →https://doi.org/10.1002/mp.12820openalex-snapshot
Radiomics analysis of pulmonary nodules in low‐dose CT for early detection of lung cancer
inferredcites →https://doi.org/10.1007/s00204-016-1771-2openalex-snapshot
Single nucleotide polymorphisms in DNA repair genes and putative cancer risk
inferredcites →https://doi.org/10.1007/s00268-017-4086-4openalex-snapshot
The Advent of Ultra‐high Volume Thoracic Surgical Centers in Shanghai
inferredcites →https://doi.org/10.1007/s00280-018-3597-5openalex-snapshot
Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer
inferredcites →https://doi.org/10.1007/s00432-015-2081-4openalex-snapshot
Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations
inferredcites →https://doi.org/10.1007/s00432-016-2211-7openalex-snapshot
MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study
inferredcites →https://doi.org/10.1007/s10278-020-00355-9openalex-snapshot
The Invasiveness Classification of Ground-Glass Nodules Using 3D Attention Network and HRCT
inferredcites →https://doi.org/10.1007/s11523-016-0460-7openalex-snapshot
Ceritinib: a Review in ALK-Positive Advanced NSCLC
inferredcites →https://doi.org/10.1007/s11523-021-00794-6openalex-snapshot
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study
inferredcites →https://doi.org/10.1007/s11548-019-02097-8openalex-snapshot
A manifold learning regularization approach to enhance 3D CT image-based lung nodule classification
inferredcites →https://doi.org/10.1007/s11604-013-0264-yopenalex-snapshot
Kurtosis and skewness assessments of solid lung nodule density histograms: differentiating malignant from benign nodules on CT
inferredcites →https://doi.org/10.1007/s12011-020-02240-6openalex-snapshot
Lung Cancer Occurrence—Correlation with Serum Chromium Levels and Genotypes
inferredcites →https://doi.org/10.1007/s40265-017-0776-3openalex-snapshot
Brigatinib: First Global Approval
inferredcites →https://doi.org/10.1007/s40265-018-0916-4openalex-snapshot
Targeting EGFR in Lung Cancer: Current Standards and Developments
inferredcites →https://doi.org/10.1016/0277-9536(94)90314-xopenalex-snapshot
Depression and the development of cancer: A meta-analysis
inferredcites →https://doi.org/10.1016/j.annonc.2020.10.479openalex-snapshot
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
inferredcites →https://doi.org/10.1016/j.annonc.2021.08.2120openalex-snapshot
LBA9 IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC
inferredcites →https://doi.org/10.1016/j.annonc.2022.02.095openalex-snapshot
85P Adjuvant osimertinib in patients (pts) with stage IB–IIIA EGFR mutation-positive (EGFRm) NSCLC after complete tumour resection: ADAURA China subgroup analysis
inferredcites →https://doi.org/10.1016/j.athoracsur.2019.08.017openalex-snapshot
Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China
inferredcites →https://doi.org/10.1016/j.cell.2007.11.025openalex-snapshot
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
inferredcites →https://doi.org/10.1016/j.chest.2017.12.027openalex-snapshot
Adoption Rate of Video-Assisted Thoracic Surgery for Lung Cancer Varies Widely in China
inferredcites →https://doi.org/10.1016/j.cllc.2017.10.004openalex-snapshot
Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1016/j.cllc.2020.06.016openalex-snapshot
Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non–Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab
inferredcites →https://doi.org/10.1016/j.cmpb.2022.106660openalex-snapshot
Prediction of lung cancer risk based on age and smoking history
inferredcites →https://doi.org/10.1016/j.critrevonc.2016.02.012openalex-snapshot
BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
inferredcites →https://doi.org/10.1016/j.ejca.2017.07.036openalex-snapshot
The changing diagnostic pathway for lung cancer patients in Shanghai, China
inferredcites →https://doi.org/10.1016/j.envint.2015.11.007openalex-snapshot
Particulate matter air pollution components and risk for lung cancer
inferredcites →https://doi.org/10.1016/j.envres.2019.108748openalex-snapshot
Short-term association between ambient air pollution and lung cancer mortality
inferredcites →https://doi.org/10.1016/j.jncc.2020.12.001openalex-snapshot
Cancer incidence and mortality in China, 2015
inferredcites →https://doi.org/10.1016/j.jtcvs.2009.08.026openalex-snapshot
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database
inferredcites →https://doi.org/10.1016/j.jtho.2015.09.014openalex-snapshot
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
inferredcites →https://doi.org/10.1016/j.jtho.2016.11.2225openalex-snapshot
EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients
inferredcites →https://doi.org/10.1016/j.jtho.2016.11.2228openalex-snapshot
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
inferredcites →https://doi.org/10.1016/j.jtho.2018.05.013openalex-snapshot
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
inferredcites →https://doi.org/10.1016/j.jtho.2018.06.012openalex-snapshot
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1016/j.jtho.2018.08.154openalex-snapshot
MS16.02 NELCIN B3 Screening Program in China
inferredcites →https://doi.org/10.1016/j.jtho.2018.12.006openalex-snapshot
EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
inferredcites →https://doi.org/10.1016/j.jtho.2018.12.013openalex-snapshot
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways
inferredcites →https://doi.org/10.1016/j.jtho.2019.01.020openalex-snapshot
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
inferredcites →https://doi.org/10.1016/j.jtho.2019.03.007openalex-snapshot
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study
inferredcites →https://doi.org/10.1016/j.jtho.2020.01.017openalex-snapshot
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
inferredcites →https://doi.org/10.1016/j.jtho.2020.04.028openalex-snapshot
Lung Cancer in People’s Republic of China
inferredcites →https://doi.org/10.1016/j.jtho.2020.07.014openalex-snapshot
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
inferredcites →https://doi.org/10.1016/j.jtho.2020.09.001openalex-snapshot
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
inferredcites →https://doi.org/10.1016/j.jtho.2020.10.155openalex-snapshot
Lung Cancer in Republic of China
inferredcites →https://doi.org/10.1016/j.jtho.2020.11.026openalex-snapshot
Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
inferredcites →https://doi.org/10.1016/j.jtho.2021.01.320openalex-snapshot
PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
inferredcites →https://doi.org/10.1016/j.jtho.2021.02.016openalex-snapshot
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project
inferredcites →https://doi.org/10.1016/j.jtho.2021.03.025openalex-snapshot
Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study
inferredcites →https://doi.org/10.1016/j.jtho.2021.04.011openalex-snapshot
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
inferredcites →https://doi.org/10.1016/j.jtho.2021.04.013openalex-snapshot
Over-Time Risk of Lung Cancer Is Largely Owing to Continuing Smoking Exposition: A Good Reason to Quit
inferredcites →https://doi.org/10.1016/j.jtho.2021.05.005openalex-snapshot
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
inferredcites →https://doi.org/10.1016/j.jtho.2021.06.017openalex-snapshot
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
inferredcites →https://doi.org/10.1016/j.jtho.2021.07.009openalex-snapshot
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
inferredcites →https://doi.org/10.1016/j.jtho.2021.08.111openalex-snapshot
MA02.01 Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial
inferredcites →https://doi.org/10.1016/j.jtho.2021.08.112openalex-snapshot
MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
inferredcites →https://doi.org/10.1016/j.jtho.2021.08.181openalex-snapshot
MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
inferredcites →https://doi.org/10.1016/j.jtho.2021.09.014openalex-snapshot
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
inferredcites →https://doi.org/10.1016/j.jtho.2021.10.014openalex-snapshot
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
inferredcites →https://doi.org/10.1016/j.jtho.2021.10.024openalex-snapshot
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
inferredcites →https://doi.org/10.1016/j.jtho.2021.11.018openalex-snapshot
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
inferredcites →https://doi.org/10.1016/j.jtocrr.2021.100163openalex-snapshot
Trends in Molecular Testing of Lung Cancer in Mainland People’s Republic of China Over the Decade 2010 to 2019
inferredcites →https://doi.org/10.1016/j.jtocrr.2023.100621openalex-snapshot
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
inferredcites →https://doi.org/10.1016/j.lungcan.2013.06.025openalex-snapshot
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
inferredcites →https://doi.org/10.1016/j.lungcan.2015.11.006openalex-snapshot
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
inferredcites →https://doi.org/10.1016/j.lungcan.2017.08.021openalex-snapshot
EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study
inferredcites →https://doi.org/10.1016/j.lungcan.2018.01.003openalex-snapshot
Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening
inferredcites →https://doi.org/10.1016/j.lungcan.2018.05.002openalex-snapshot
Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients
inferredcites →https://doi.org/10.1016/j.lungcan.2019.01.016openalex-snapshot
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study
inferredcites →https://doi.org/10.1016/j.lungcan.2019.05.008openalex-snapshot
Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study
inferredcites →https://doi.org/10.1016/j.lungcan.2019.06.012openalex-snapshot
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
inferredcites →https://doi.org/10.1016/j.lungcan.2021.12.002openalex-snapshot
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
inferredcites →https://doi.org/10.1016/j.mri.2012.06.010openalex-snapshot
Radiomics: the process and the challenges
inferredcites →https://doi.org/10.1016/j.prp.2020.152873openalex-snapshot
Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population
inferredcites →https://doi.org/10.1016/j.pupt.2021.102084openalex-snapshot
Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma
inferredcites →https://doi.org/10.1016/j.sleep.2021.06.044openalex-snapshot
Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study
inferredcites →https://doi.org/10.1016/s0140-6736(12)61085-xopenalex-snapshot
Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
inferredcites →https://doi.org/10.1016/s0140-6736(13)62159-5openalex-snapshot
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
inferredcites →https://doi.org/10.1016/s0140-6736(16)31473-8openalex-snapshot
New and emerging targeted treatments in advanced non-small-cell lung cancer
inferredcites →https://doi.org/10.1016/s0140-6736(17)30123-xopenalex-snapshot
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
inferredcites →https://doi.org/10.1016/s0140-6736(18)32409-7openalex-snapshot
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
inferredcites →https://doi.org/10.1016/s0140-6736(21)02098-5openalex-snapshot
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(06)70804-xopenalex-snapshot
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(10)70087-5openalex-snapshot
New driver mutations in non-small-cell lung cancer
inferredcites →https://doi.org/10.1016/s1470-2045(15)70046-xopenalex-snapshot
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
inferredcites →https://doi.org/10.1016/s1470-2045(17)30679-4openalex-snapshot
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30680-0openalex-snapshot
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
inferredcites →https://doi.org/10.1016/s1470-2045(20)30453-8openalex-snapshot
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(21)00630-6openalex-snapshot
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(21)00650-1openalex-snapshot
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
inferredcites →https://doi.org/10.1016/s2213-2600(18)30277-7openalex-snapshot
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
inferredcites →https://doi.org/10.1016/s2213-2600(19)30053-0openalex-snapshot
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
inferredcites →https://doi.org/10.1016/s2213-2600(19)30084-0openalex-snapshot
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
inferredcites →https://doi.org/10.1016/s2213-2600(19)30144-4openalex-snapshot
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
inferredcites →https://doi.org/10.1016/s2213-2600(19)30252-8openalex-snapshot
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
inferredcites →https://doi.org/10.1016/s2213-2600(20)30365-9openalex-snapshot
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
inferredcites →https://doi.org/10.1016/s2213-2600(20)30455-0openalex-snapshot
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
inferredcites →https://doi.org/10.1016/s2213-2600(21)00084-9openalex-snapshot
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
inferredcites →https://doi.org/10.1016/s2213-2600(21)00134-xopenalex-snapshot
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
inferredcites →https://doi.org/10.1016/s2542-5196(20)30161-3openalex-snapshot
The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990–2017: an analysis for the Global Burden of Disease Study 2017
inferredcites →https://doi.org/10.1038/513s2aopenalex-snapshot
Epidemiology: The dominant malignancy
inferredcites →https://doi.org/10.1038/nature05945openalex-snapshot
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
inferredcites →https://doi.org/10.1038/nature12796openalex-snapshot
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
inferredcites →https://doi.org/10.1038/ng.2351openalex-snapshot
Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population
inferredcites →https://doi.org/10.1038/ng.3892openalex-snapshot
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
inferredcites →https://doi.org/10.1038/ng.875openalex-snapshot
A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese
inferredcites →https://doi.org/10.1038/nrclinonc.2013.136openalex-snapshot
Time to ESCAPE the city? Air pollution linked to lung cancer
inferredcites →https://doi.org/10.1038/nrclinonc.2014.104openalex-snapshot
Acquired resistance to TKIs in solid tumours: learning from lung cancer
inferredcites →https://doi.org/10.1038/s41379-019-0339-0openalex-snapshot
The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population
inferredcites →https://doi.org/10.1038/s41416-019-0573-8openalex-snapshot
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
inferredcites →https://doi.org/10.1038/s41591-018-0007-9openalex-snapshot
Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
inferredcites →https://doi.org/10.1038/s41591-019-0716-8openalex-snapshot
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
inferredcites →https://doi.org/10.1038/s41598-021-84012-3openalex-snapshot
Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
inferredcites →https://doi.org/10.1056/nejm197111182852108openalex-snapshot
Tumor Angiogenesis: Therapeutic Implications
inferredcites →https://doi.org/10.1056/nejm199401203300301openalex-snapshot
A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa011954openalex-snapshot
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa031644openalex-snapshot
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa043623openalex-snapshot
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa061884openalex-snapshot
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1102873openalex-snapshot
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
inferredcites →https://doi.org/10.1056/nejmoa1406766openalex-snapshot
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1408440openalex-snapshot
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1612674openalex-snapshot
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1709937openalex-snapshot
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1713137openalex-snapshot
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1716948openalex-snapshot
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
inferredcites →https://doi.org/10.1056/nejmoa1809697openalex-snapshot
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
inferredcites →https://doi.org/10.1056/nejmoa1913662openalex-snapshot
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
inferredcites →https://doi.org/10.1056/nejmoa1916623openalex-snapshot
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
inferredcites →https://doi.org/10.1056/nejmoa1917346openalex-snapshot
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
inferredcites →https://doi.org/10.1056/nejmoa2002787openalex-snapshot
Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa2004407openalex-snapshot
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
inferredcites →https://doi.org/10.1056/nejmoa2005653openalex-snapshot
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa2027071openalex-snapshot
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa2027187openalex-snapshot
First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa2103695openalex-snapshot
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
inferredcites →https://doi.org/10.1056/nejmoa2112431openalex-snapshot
Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1073/pnas.0702916104openalex-snapshot
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
inferredcites →https://doi.org/10.1093/aje/kwz187openalex-snapshot
Exposure to Welding Fumes, Hexavalent Chromium, or Nickel and Risk of Lung Cancer
inferredcites →https://doi.org/10.1093/annonc/mdi126openalex-snapshot
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin
inferredcites →https://doi.org/10.1093/annonc/mdl377openalex-snapshot
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
inferredcites →https://doi.org/10.1093/annonc/mds578openalex-snapshot
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
inferredcites →https://doi.org/10.1093/annonc/mdv381openalex-snapshot
Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1093/annonc/mdx009openalex-snapshot
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
inferredcites →https://doi.org/10.1093/annonc/mdy121openalex-snapshot
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
inferredcites →https://doi.org/10.1093/annonc/mdy405openalex-snapshot
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study
inferredcites →https://doi.org/10.1093/ejcts/ezt015openalex-snapshot
Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis
inferredcites →https://doi.org/10.1093/jnci/86.9.673openalex-snapshot
A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1093/jnci/djab143openalex-snapshot
Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females
inferredcites →https://doi.org/10.1093/jnci/djq346openalex-snapshot
Cancer Risks After Radiation Exposure in Middle Age
inferredcites →https://doi.org/10.1093/jnci/djr325openalex-snapshot
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
inferredcites →https://doi.org/10.1093/jnci/dju284openalex-snapshot
Projected Outcomes Using Different Nodule Sizes to Define a Positive CT Lung Cancer Screening Examination
inferredcites →https://doi.org/10.1097/cm9.0000000000001474openalex-snapshot
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
inferredcites →https://doi.org/10.1097/jto.0000000000000033openalex-snapshot
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
inferredcites →https://doi.org/10.1097/jto.0000000000000043openalex-snapshot
Preselection Based on Clinical Characteristics in German Non–Small-Cell Lung Cancer Patients Screened for EML4-ALK Translocation
inferredcites →https://doi.org/10.1097/jto.0000000000000130openalex-snapshot
Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
inferredcites →https://doi.org/10.1097/jto.0000000000000146openalex-snapshot
Cisplatin versus Carboplatin-Based Regimens for the Treatment of Patients with Metastatic Lung Cancer. An Analysis of Veterans Health Administration Data
inferredcites →https://doi.org/10.1097/jto.0000000000000606openalex-snapshot
Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1097/jto.0000000000000630openalex-snapshot
The 2015 World Health Organization Classification of Lung Tumors
inferredcites →https://doi.org/10.1097/jto.0b013e31819cce50openalex-snapshot
Lymph Node Dissection for Lung Cancer: Significance, Strategy, and Technique
inferredcites →https://doi.org/10.1097/jto.0b013e31824c7f7aopenalex-snapshot
A Novel Mass Spectrometry–Based Assay for Diagnosis of EML4-ALK–Positive Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1097/mcp.0000000000000349openalex-snapshot
Radiation exposure and lung disease in today's nuclear world
inferredcites →https://doi.org/10.1097/ppo.0000000000000101openalex-snapshot
Lifestyle and Cancer Risk
inferredcites →https://doi.org/10.1097/rti.0000000000000538openalex-snapshot
The Regimen of Computed Tomography Screening for Lung Cancer
inferredcites →https://doi.org/10.1111/1759-7714.12121openalex-snapshot
Histological subtypes of lung cancer in Chinese women from 2000 to 2012
inferredcites →https://doi.org/10.1111/1759-7714.12859openalex-snapshot
Real‐world EGFR testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study
inferredcites →https://doi.org/10.1111/1759-7714.13577openalex-snapshot
Status of 10 targeted genes of non‐small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution
inferredcites →https://doi.org/10.1111/ajco.13664openalex-snapshot
Asbestos‐related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation
inferredcites →https://doi.org/10.1126/scitranslmed.3007094openalex-snapshot
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
inferredcites →https://doi.org/10.1136/jech-2013-203675openalex-snapshot
Stressful social relations and mortality: a prospective cohort study
inferredcites →https://doi.org/10.1136/jitc-2021-003027openalex-snapshot
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS- mutated non-small cell lung cancer with STK11 , KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
inferredcites →https://doi.org/10.1136/thoraxjnl-2015-208054openalex-snapshot
The short-term association between asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in Hong Kong: a time-series study
inferredcites →https://doi.org/10.1155/2017/8314740openalex-snapshot
Using Deep Learning for Classification of Lung Nodules on Computed Tomography Images
inferredcites →https://doi.org/10.1158/0008-5472.can-04-0083openalex-snapshot
Disruption of Cancer Cell Replication by Alternating Electric Fields
inferredcites →https://doi.org/10.1158/1055-9965.epi-10-0437openalex-snapshot
Global Patterns of Cancer Incidence and Mortality Rates and Trends
inferredcites →https://doi.org/10.1158/1055-9965.epi-16-0794openalex-snapshot
A Decade of GWAS Results in Lung Cancer
showing the first 200 of 301 · page through all 301

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4516020openalex-extracted
Mettl3 Mediated Mir-196a Up-Regulation Promotes Cell Proliferation and Autophagy Through Gas7 in Nsclc
inferred← citeshttps://doi.org/10.2139/ssrn.4985156openalex-extracted
Machine Learning-Derived Prognostic Signature Based on Genes-Associated with 19 Types of Programmed Cell Death in Lung Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1002/adfm.202502087openalex-snapshot
Spatio‐Temporally Profiling Human Lung Cancer Surgery With a FRET‐Mediated AIEgen‐Active Nanoprobe
inferred← citeshttps://doi.org/10.1002/adhm.202404612openalex-snapshot
Inducing Cuproptosis with Copper Ion‐Loaded Aloe Emodin Self‐Assembled Nanoparticles for Enhanced Tumor Photodynamic Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202413387openalex-snapshot
Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect
inferred← citeshttps://doi.org/10.1002/advs.202510197openalex-snapshot
EGFR Targeted Liposomal PROTAC Assisted With Epigenetic Regulation as an Efficient Strategy for Osimertinib‐Resistant Lung Cancer Therapy
inferred← citeshttps://doi.org/10.1002/advs.77528openalex-snapshot
DLST Succinylation‐Mediated Mitochondrial Metabolic Remodeling and Cuproptosis Resistance Promote Malignant Progression of Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/ame2.12355openalex-snapshot
Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients
inferred← citeshttps://doi.org/10.1002/cac2.12627openalex-snapshot
Cancer situation in China: an analysis based on the global epidemiological data released in 2024
inferred← citeshttps://doi.org/10.1002/cac2.12633openalex-snapshot
Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6616openalex-snapshot
Pain experience of lung cancer patients during home recovery after surgery: A qualitative descriptive study
inferred← citeshttps://doi.org/10.1002/cam4.71980openalex-snapshot
The hsa_circ_0070354/ miR ‐4322/ RAB3B Axis Facilitates the Carcinogenesis and Development of Non‐Small Cell Lung Cancer ( NSCLC )
inferred← citeshttps://doi.org/10.1002/cam4.7227openalex-snapshot
Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival
inferred← citeshttps://doi.org/10.1002/cbdv.202500114openalex-snapshot
20‐Acetylsinularolide B (ASB) From Lobophytum crassum Exhibits Anticancer Activity In Vitro Through IGF1R/PI3K/AKT/mTOR Pathway
inferred← citeshttps://doi.org/10.1002/cbf.4072openalex-snapshot
Emerging roles of long noncoding RNA H19 in human lung cancer
inferred← citeshttps://doi.org/10.1002/cbin.12197openalex-snapshot
PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25
inferred← citeshttps://doi.org/10.1002/cncr.35111openalex-snapshot
Metformin as a booster or obstacle of immunotherapy in patients with non–small cell lung cancer and diabetes mellitus
inferred← citeshttps://doi.org/10.1002/ctm2.70156openalex-snapshot
Unravelling the prognostic and operative role of intratumoural microbiota in non‐small cell lung cancer: Insights from 16S rRNA and RNA sequencing
inferred← citeshttps://doi.org/10.1002/ctm2.70744openalex-snapshot
An interpretable multi‐task whole‐slide histopathology AI model for non‐small cell lung cancer: Cross‐cohort generalisation, spatial attention–transcriptomic integration, and molecular–immune profiling
inferred← citeshttps://doi.org/10.1002/exp.20220170openalex-snapshot
A self‐assembled, genetically engineered, irradiated tumor cell debris vaccine
inferred← citeshttps://doi.org/10.1002/fsn3.70862openalex-snapshot
Anti‐Lung Cancer Effects and Related Mechanisms of α‐Caryophyllene In Vitro and In Vivo
inferred← citeshttps://doi.org/10.1002/jbt.70338openalex-snapshot
Evaluation of the Efficacy and Safety of DC‐CIK Bioimmunotherapy in the Treatment of Advanced Non‐Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1002/jcp.31370openalex-snapshot
Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics
inferred← citeshttps://doi.org/10.1002/jso.27610openalex-snapshot
Can cell‐free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I−III a nonsmall cell lung cancer (NSCLC)? A pilot study
inferred← citeshttps://doi.org/10.1002/kjm2.70070openalex-snapshot
KLF1 Promotes Non‐Small Cell Lung Cancer Cell Proliferation and Invasion by Upregulating the LINC02159 / DYNC1H1 Pathway
inferred← citeshttps://doi.org/10.1002/mc.23922openalex-snapshot
Four‐gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/mco2.70154openalex-snapshot
Identifying the Intergenic ALK Fusion LOC388942‐ALK as a Driver of Non–Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1002/mp.17414openalex-snapshot
A vision transformer‐based deep transfer learning nomogram for predicting lymph node metastasis in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/mp.17775openalex-snapshot
Lung cancer dose distribution prediction based on a dual‐branch feature extraction network
inferred← citeshttps://doi.org/10.1002/ncp.11336openalex-snapshot
Systematic inflammation burdens improve the survival prediction value of nutrition assessment in postoperative patients with recurrent or metastatic cancer: A retrospective observational study
inferred← citeshttps://doi.org/10.1002/prm2.12146openalex-snapshot
Identification of expression profiles and transcription factors during EGFR ‐ TKI acquired resistance in LUAD
inferred← citeshttps://doi.org/10.1002/ptr.70130openalex-snapshot
Harringtonine Elicits Ferroptosis by Regulating SYVN1 ‐Mediated FASN Ubiquitination for Evoking Anti‐Lung Cancer Efficacy
inferred← citeshttps://doi.org/10.1002/ptr.70242openalex-snapshot
20(R)‐Ginsenoside Rg3 Suppresses P‐Glycoprotein‐Mediated Multidrug Resistance in A549 /Taxol Cells by Targeting MDM2 ‐ IκB ‐α Signaling Axis
inferred← citeshttps://doi.org/10.1002/ptr.8242openalex-snapshot
Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer
inferred← citeshttps://doi.org/10.1002/slct.202403174openalex-snapshot
Membrane Permeability and Drug Targeting Potential of Phospholipid‐Based Nanocarriers in Lung Cancer Therapy
inferred← citeshttps://doi.org/10.1002/tox.24282openalex-snapshot
Comprehensive analysis of lung adenocarcinoma: Unveiling differential gene expression, survival‐linked genes, subtype stratification, and immune landscape implications
inferred← citeshttps://doi.org/10.1007/s00011-025-02088-3openalex-snapshot
RUNX1 promotes NSCLC progression by ACP5/SMAD3-mediated M2 macrophage polarization
inferred← citeshttps://doi.org/10.1007/s00044-025-03431-3openalex-snapshot
Synthesis, characterization and in vitro antitumor activity of asiatic acid derivatives
inferred← citeshttps://doi.org/10.1007/s00210-024-03328-9openalex-snapshot
Auriculasin induces mitochondrial oxidative stress and drives ferroptosis by inhibiting PI3K/Akt pathway in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s00210-024-03481-1openalex-snapshot
Exploring the anti-NSCLC mechanism of phillyrin targeting inhibition of the HSP90-AKT pathway
inferred← citeshttps://doi.org/10.1007/s00262-024-03666-wopenalex-snapshot
Prenatal inflammation exposure accelerates lung cancer tumorigenesis in offspring mouse: possible links to IRE1α/XBP1-mediated M2-like polarization of TAMs and PD-L1 up-expression
inferred← citeshttps://doi.org/10.1007/s00262-024-03881-5openalex-snapshot
High CD38 expression defines a mitochondrial function-adapted CD8+ T cell subset with implications for lung cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-025-04166-1openalex-snapshot
Comprehensive proteomic and pathological profiling identifies PRAS40 as a novel biomarker and mediator of primary immune checkpoint blockade resistance in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s00262-025-04227-5openalex-snapshot
Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study
inferred← citeshttps://doi.org/10.1007/s00262-026-04338-7openalex-snapshot
A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer
inferred← citeshttps://doi.org/10.1007/s00280-025-04780-xopenalex-snapshot
Effect of Metformin on vascular endothelial injury in patients with non-small cell lung cancer treated with chemotherapy combined with bevacizumab
inferred← citeshttps://doi.org/10.1007/s00280-025-04853-xopenalex-snapshot
Association between modifications in intravenous chemotherapy dose and disease-free survival and related influencing factors in lung cancer patients: a retrospective study based on inverse probability weighting
inferred← citeshttps://doi.org/10.1007/s00330-026-12763-6openalex-snapshot
Malignancy risk and contrast-enhanced ultrasound guidance in non-diagnostic biopsies of peripheral lung lesions: a multicenter study
inferred← citeshttps://doi.org/10.1007/s00335-026-10202-xopenalex-snapshot
Hypoxia-induced circ_0017521 enhances glycolysis and promotes NSCLC progression via upregulating the PFKFB3/PI3K-AKT pathway
inferred← citeshttps://doi.org/10.1007/s00432-023-05490-8openalex-snapshot
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s00432-023-05586-1openalex-snapshot
Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer progression by targeting CRKL
inferred← citeshttps://doi.org/10.1007/s00438-026-02460-wopenalex-snapshot
Lactate derived from CAFs mediates H3K18la in stemness gene promoters, which promotes tumor malignant phenotype formation
inferred← citeshttps://doi.org/10.1007/s00726-023-03361-7openalex-snapshot
A novel lncRNA-hidden polypeptide regulates malignant phenotypes and pemetrexed sensitivity in A549 pulmonary adenocarcinoma cells
inferred← citeshttps://doi.org/10.1007/s10238-026-02184-6openalex-snapshot
A review of deep learning-based multimodal data integration of lung cancer
inferred← citeshttps://doi.org/10.1007/s10278-026-01954-8openalex-snapshot
Interpretable Deep Learning with Multi-Scale CT for Predicting Occult Lymph Node Metastasis in Early-Stage NSCLC: A Multicenter Study
inferred← citeshttps://doi.org/10.1007/s10528-023-10526-2openalex-snapshot
LncRNA KCNQ1OT1/miR-496/HMGB1 Signaling Axis Promotes Invasion and Migration of Non-small Cell Lung Cancer Cells
inferred← citeshttps://doi.org/10.1007/s10528-023-10641-0openalex-snapshot
circRNA-CPA4 Regulates Cell Proliferation and Apoptosis of Non-small Cell Lung Cancer via the miR-1183/PDPK1 Axis
inferred← citeshttps://doi.org/10.1007/s10585-026-10399-wopenalex-snapshot
LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axis
inferred← citeshttps://doi.org/10.1007/s10637-025-01521-yopenalex-snapshot
Rare exon 18 G719A and exon 21 L833V compound EGFR mutations show favorable response to Third-Generation TKI Furmonertinib: A case report and literature review
inferred← citeshttps://doi.org/10.1007/s10735-026-10731-4openalex-snapshot
The IGF2BP3/SLC2A1 axis mediates hsa_circ_0000376-Induced malignant progression and neutrophil N2 polarization in the lung adenocarcinoma microenvironment
inferred← citeshttps://doi.org/10.1007/s11010-023-04851-8openalex-snapshot
RETRACTED ARTICLE: Upregulation of MCL-1 by LUCAT1 through interacting with SRSF1 promotes the migration and invasion in non-small cell lung carcinoma
inferred← citeshttps://doi.org/10.1007/s11030-023-10789-2openalex-snapshot
Discovery of Palbociclib as a potent c-Myc G4 stabilizer for lung cancer treatment using molecular docking, molecular dynamics simulation, and in vitro activity evaluation
inferred← citeshttps://doi.org/10.1007/s11033-024-09941-4openalex-snapshot
Evaluation of the role of EGFR exon 19 747–750 deletion mutation and plasma amino acid profile in the development of lung cancer
inferred← citeshttps://doi.org/10.1007/s11325-023-02917-xopenalex-snapshot
The association between sleep duration and lung cancer: a meta-analysis
inferred← citeshttps://doi.org/10.1007/s12032-026-03242-5openalex-snapshot
Intracellular and exosomal miR-101-3p regulated by METTL14 confers Gefitinib sensitivity in NSCLC
inferred← citeshttps://doi.org/10.1007/s12033-024-01198-3openalex-snapshot
SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration
inferred← citeshttps://doi.org/10.1007/s12094-023-03376-2openalex-snapshot
Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s12094-024-03423-6openalex-snapshot
Circulating serum exosomes i-tRF-AspGTC and tRF-1-SerCGA as diagnostic indicators for non-small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s12094-024-03442-3openalex-snapshot
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1007/s12094-025-03966-2openalex-snapshot
Genomic alteration correlates with programmed cell death ligand 1 (PD-L1) expression in 2750 Chinese non-small-cell lung cancer patients
inferred← citeshttps://doi.org/10.1007/s12274-023-6273-yopenalex-snapshot
Formulated nano-liposomes for reversal of cisplatin resistance in NSCLC with nucleus-targeting peptide
inferred← citeshttps://doi.org/10.1007/s12325-023-02679-8openalex-snapshot
Biomarkers-Based Cost-Effectiveness of Toripalimab Plus Chemotherapy for Patients with Treatment-Naive Advanced Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1007/s12672-024-01361-xopenalex-snapshot
Codonopsis pilosula polysaccharide suppresses the progression of non-small cell lung cancer by triggering NLRP3/GSDMD-dependent pyroptosis
inferred← citeshttps://doi.org/10.1007/s12672-024-01552-6openalex-snapshot
Aberrant expression of MRAS and HEG1 as the biomarkers for osimertinib resistance in LUAD
inferred← citeshttps://doi.org/10.1007/s12672-025-02330-8openalex-snapshot
The m6A methyltransferase METTL3 affects ferroptosis in non-small cell lung cancer by regulating the PTEN/PI3K/AKT pathway
inferred← citeshttps://doi.org/10.1007/s12672-025-03330-4openalex-snapshot
Hsa_circ_0075451 promotes NSCLC proliferation, metastasis, and glycolysis through interaction with the RNA-binding protein RBM4
inferred← citeshttps://doi.org/10.1007/s12672-025-03600-1openalex-snapshot
Multiomic Mendelian randomization analysis of metabolic gene methylation expression and protein levels in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s12672-025-04116-4openalex-snapshot
Exploring targeted therapies against RFPL3 for non-small cell lung cancer with lymph node metastasis
inferred← citeshttps://doi.org/10.1007/s12672-026-04873-wopenalex-snapshot
Integration of machine learning-based screening approaches and single-cell sequencing technique to identify cancer stemness genes associated with radiotherapy resistance in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s12672-026-04955-9openalex-snapshot
LINC00886 inhibits the proliferation, migration, and invasion of NSCLC cells by sponging miR-141-5p
inferred← citeshttps://doi.org/10.1007/s12672-026-05074-1openalex-snapshot
The role of the miR-200a-5p/NFIA axis in the progression and clinical prognosis of non-small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s12672-026-05258-9openalex-snapshot
Comprehensive bioinformatics analysis of EXOSC family genes in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s12672-026-05286-5openalex-snapshot
Exploratory multiomics analysis identifies WDR17 as a potential biomarker of tyrosine kinase inhibitor resistance in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s13273-026-00646-2openalex-snapshot
Osthole promotes cell senescence-like phenotype to enhance radiosensitivity in non-small cell lung carcinoma possibly through modulating the Sirt1/NF-κB pathway
inferred← citeshttps://doi.org/10.1007/s13402-025-01101-5openalex-snapshot
Effect of neoadjuvant targeted therapy on the tumor microenvironment in resectable lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s13402-026-01212-7openalex-snapshot
EBF3 suppresses lung adenocarcinoma progression and immune evasion via transcriptional repression of CCL24
inferred← citeshttps://doi.org/10.1007/s13402-026-01238-xopenalex-snapshot
Radiation induces an EGFR-dependent lactate-epigenetic program underlying synergy with EGFR inhibition
inferred← citeshttps://doi.org/10.1007/s13721-025-00695-yopenalex-snapshot
A machine learning computational framework develops a glutamine metabolism immunity index for improving clinical outcomes in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s40265-023-01946-wopenalex-snapshot
Befotertinib: First Approval
inferred← citeshttps://doi.org/10.1007/s40336-024-00676-7openalex-snapshot
The landscape of radiomics in clinical oncology research
inferred← citeshttps://doi.org/10.1007/s40487-025-00361-3openalex-snapshot
Pharmacoeconomic Analysis of Brigatinib versus Alectinib in First‑Line Treatment of Anaplastic Lymphoma Kinase‑Positive Advanced Non‑Small‑Cell Lung Cancer in China
inferred← citeshttps://doi.org/10.1007/s40487-026-00465-4openalex-snapshot
Real-World First-Line Treatment Characteristics and Physician Drivers in Advanced/Metastatic Non–Small Cell Lung Cancer, PD-L1 ≥ 50%, and without Actionable Genomic Alterations
inferred← citeshttps://doi.org/10.1007/s43657-024-00206-5openalex-snapshot
Identification of High-Performing Blood Metabolite Biomarkers of Lung Cancer in a Chinese Population
inferred← citeshttps://doi.org/10.1007/s44178-025-00177-1openalex-snapshot
CT-based radiomics analysis for predicting EGFR and ALK mutational status in non‑small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s44178-025-00193-1openalex-snapshot
Efficacy and safety of neoadjuvant chemoimmunotherapy in elderly patients with resectable non-small cell lung cancer: a network meta-analysis and systematic review
inferred← citeshttps://doi.org/10.1007/s44178-026-00276-7openalex-snapshot
Antibody–drug conjugates in non-small cell lung cancer: current landscape and future directions
inferred← citeshttps://doi.org/10.1016/b978-0-443-30120-9.00014-3openalex-snapshot
Ionizing and nonionizing radiation linked to lung cancer
inferred← citeshttps://doi.org/10.1016/b978-0-443-44585-9.00002-0openalex-snapshot
Nanotechnology in lung cancer therapy: Recent advancements and future perspectives in drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.abb.2026.110751openalex-snapshot
Metformin inhibits non-small cell lung cancer via lncRP11-242D8.1
inferred← citeshttps://doi.org/10.1016/j.adcanc.2025.100162openalex-snapshot
Roles of the WNT/β-catenin signaling pathway in the metastasis and recurrence of NSCLC
inferred← citeshttps://doi.org/10.1016/j.aej.2025.09.016openalex-snapshot
Modeling the co-infection dynamics between tuberculosis and lung cancer: Insights from simulations
inferred← citeshttps://doi.org/10.1016/j.amjms.2026.06.016openalex-snapshot
SHOX2 regulates TRIM29 to enhance malignant progression and EMT in lung squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.arabjc.2024.105603openalex-snapshot
Modification of a natural diterpene and its antitumor mechanism: Promoting apoptosis, suppressing migration, and inhibiting angiogenesis
inferred← citeshttps://doi.org/10.1016/j.arabjc.2024.105891openalex-snapshot
Plasma protein affinity, antioxidant, and anti-lung cancer properties of O-methylated flavonol rhamnazin
inferred← citeshttps://doi.org/10.1016/j.bbadis.2025.167965openalex-snapshot
ANXA1 facilitates myeloid-derived suppressor cell infiltration in the non-small cell lung cancer immunomicroenvironment via the STING/NF-κB/CXCL5/CXCR2 signaling axis to enhance tumor progression
inferred← citeshttps://doi.org/10.1016/j.bbagen.2024.130706openalex-snapshot
COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.bbrc.2023.149344openalex-snapshot
Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152488openalex-snapshot
CPT1A promotes the proliferation and immune evasion of lung cancer by inducing CTLA-4 K154 succinylation
inferred← citeshttps://doi.org/10.1016/j.bcp.2025.117097openalex-snapshot
Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m6A modification of SFRP2
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117863openalex-snapshot
A resveratrol derivative RVX-208 inhibits PD-1/PD-L1 to restrain non-small cell lung cancer as an immunotherapy
inferred← citeshttps://doi.org/10.1016/j.bioelechem.2025.109108openalex-snapshot
An electrochemical biosensor for immobilization coupling and quantifying exosomes based on a UiO-66 metal−organic framework
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.109002openalex-snapshot
Exploring the mechanism of Levistolide A in the treatment of lung cancer cells based on network analysis, molecular docking and experimental validation
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.109159openalex-snapshot
A comprehensive description of VEGF-R1/2 small molecule inhibitors as anticancer agents
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115171openalex-snapshot
N6-methyladenosine modification: an important player in the tumor immune microenvironment
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115514openalex-snapshot
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.116097openalex-snapshot
Molecular mechanism of α-Hederin in tumor progression
inferred← citeshttps://doi.org/10.1016/j.bja.2025.12.056openalex-snapshot
Lidocaine suppresses lung cancer metastasis by inhibiting polarisation of tumour-associated macrophages in mice
inferred← citeshttps://doi.org/10.1016/j.bspc.2025.108402openalex-snapshot
Integrating important tile filtering and pathology foundation model for lung cancer mutation prediction from pathological images
inferred← citeshttps://doi.org/10.1016/j.bspc.2025.108864openalex-snapshot
A foundation deep learning system to identify early cancer: A cohort study of multiple cancers
inferred← citeshttps://doi.org/10.1016/j.canlet.2025.218203openalex-snapshot
Strategies to optimize duration of immunotherapy in advanced NSCLC: Current evidence and future directions
inferred← citeshttps://doi.org/10.1016/j.canlet.2025.218223openalex-snapshot
Consensus on the diagnosis and treatment of unresectable stage III driver gene-positive non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.carbpol.2024.122521openalex-snapshot
Harnessing the CD44-targeted delivery of self-assembled hyaluronan nanogel to reverse the antagonism between Cisplatin and Gefitinib in NSCLC cancer therapy
inferred← citeshttps://doi.org/10.1016/j.cej.2025.166044openalex-snapshot
Modulating the metal–support interaction of Pt/CeO2 catalysts for enhanced chemodynamic therapy for lung cancer thearanostics
inferred← citeshttps://doi.org/10.1016/j.cej.2025.168071openalex-snapshot
Novel strategies for investigating radiotherapy sensitivity mechanisms: integrative multi-omics and surface-enhanced Raman spectroscopy (SERS)
inferred← citeshttps://doi.org/10.1016/j.cej.2025.169906openalex-snapshot
Nanoengineered polymeric RNA nanoflowers for dual-pathway modulation and effective therapy for non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.cellsig.2024.111414openalex-snapshot
Deacetylation by SIRT6 increases the stability of GILZ to suppress NSCLC cell migration and invasion
inferred← citeshttps://doi.org/10.1016/j.cellsig.2025.111834openalex-snapshot
LAPTM5 confers cisplatin resistance in NSCLC by suppressing LAMP1 ubiquitination to stabilize lysosomal membranes and sustain autophagic flux
inferred← citeshttps://doi.org/10.1016/j.cellsig.2025.111950openalex-snapshot
FAAP100:A biomarker based on pan-cancer analysis, promotes the progression of lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.chroma.2023.464448openalex-snapshot
Simultaneous determination of three biomarkers of non-small cells lung cancer in urine by pipette-tip solid-phase extraction coupled with liquid chromatography tandem mass spectrometry
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2025.110961openalex-snapshot
The predictive value of ferroptosis marker SLC7A11 in the prognosis of advanced non-small cell lung cancer patients
inferred← citeshttps://doi.org/10.1016/j.cllc.2025.09.004openalex-snapshot
Efficacy of Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma with Tumor Spread Through Air Spaces: A Multi-Center Real-World Study
inferred← citeshttps://doi.org/10.1016/j.clnesp.2023.12.018openalex-snapshot
Increased pretreatment triglyceride glucose-body mass index associated with poor prognosis in patients with advanced non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2023.07.012openalex-snapshot
Effect of PD-L1 Expression for the PD-1/L1 Inhibitors on Non-small Cell Lung Cancer: A Meta-analysis Based on Randomised Controlled Trials
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2026.115586openalex-snapshot
Heterogeneous inorganic nanomedicine delivery system loaded with anlotinib for enhanced treatment of non-small cell lung cancer (NSCLC)
inferred← citeshttps://doi.org/10.1016/j.cpan.2026.09.001openalex-snapshot
Association of bevacizumab added to chemotherapy and whole-brain radiotherapy with peritumoral edema and prognosis in patients with brain metastases from non-squamous non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.crad.2024.04.019openalex-snapshot
Predictive value of spectral computed tomography parameters for EGFR gene mutation in non-small–cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2024.104284openalex-snapshot
Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2025.104669openalex-snapshot
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2026.105604openalex-snapshot
Recent advances and future challenges of bispecific antibodies in lung cancer
inferred← citeshttps://doi.org/10.1016/j.crphar.2024.100212openalex-snapshot
The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
inferred← citeshttps://doi.org/10.1016/j.ctro.2024.100889openalex-snapshot
Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2023.101036openalex-snapshot
Changing trends in disease burden of lung cancer in China from 1990-2019 and following 15-year prediction
inferred← citeshttps://doi.org/10.1016/j.drup.2026.101379openalex-snapshot
Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2024.117157openalex-snapshot
Upregulated DNMT3a coupling with inhibiting p62-dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2025.118583openalex-snapshot
Cadmium-associated molecular pathways drive gender-specific pathogenesis and prognosis in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2026.119854openalex-snapshot
Environmental flame retardant EHDPP stabilizes EGFR to accelerate lung cancer progression: Integrated network toxicology, bioinformatics, and in vitro evidence
inferred← citeshttps://doi.org/10.1016/j.ejphar.2024.177131openalex-snapshot
β-carboline compound-10830733 suppresses the progression of non-small cell lung cancer by inhibiting the PI3K/Akt/GSK 3β signaling pathway
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.178685openalex-snapshot
OTUD3-mediated deubiquitination licenses TEX264 to orchestrate ER-phagy for KDM5B degradation in teniposide lung cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.179157openalex-snapshot
A derivative of cytisine N-isoflavone from Sophora alopecuroides L., suppresses non-small cell lung cancer by targeting mTOR
inferred← citeshttps://doi.org/10.1016/j.envpol.2025.126108openalex-snapshot
Dynamic characteristics of metabolism and small extracellular vesicles during malignant transformation of BEAS-2B cells induced by coal tar pitch extract
inferred← citeshttps://doi.org/10.1016/j.esmoop.2024.103996openalex-snapshot
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.fbio.2025.106504openalex-snapshot
Astragalus polysaccharide exhibits immune-enhancing effects in gemcitabine chemotherapy by regulating tumor-associated macrophages polarization via the toll-like receptor-4/nuclear factor-κB/signal transducer and activator of transcription 3 pathway
inferred← citeshttps://doi.org/10.1016/j.gene.2024.149002openalex-snapshot
Ferroptosis related CPT1A and GDF15 gene polymorphisms are risk factors for lung adenocarcinoma: A case-control study
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e24811openalex-snapshot
Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e27282openalex-snapshot
Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29290openalex-snapshot
Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29404openalex-snapshot
Qingfei mixture modulates the immune responses in lung cancer through modulating mTOR signaling and gut microbiota-derived short-chain fatty acids
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e33888openalex-snapshot
Development and validation of a TAAbs and TAAs based non-invasive model for diagnosing lung cancer
inferred← citeshttps://doi.org/10.1016/j.hlife.2024.01.003openalex-snapshot
Discoidin domain receptor 1 as a potent therapeutic target in solid tumors
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.132058openalex-snapshot
ICG-labeled PD-L1-antagonistic affibody dimer for tumor imaging and enhancement of tumor photothermal-immunotherapy
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.132797openalex-snapshot
Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.133594openalex-snapshot
Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-β signaling pathway
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.138211openalex-snapshot
Study on the inhibition of non-small cell lung cancer mediated by chitosan-based gene carrier delivering STAT3-shRNA
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.143413openalex-snapshot
Interaction of vernodalin with p38 mitogen-activated protein kinase (p38 MAPK) and subsequent effects in lung cancer cell model
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.111147openalex-snapshot
Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.111918openalex-snapshot
SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113564openalex-snapshot
ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113588openalex-snapshot
Machine learning identifies immune-based biomarkers that predict efficacy of anti-angiogenesis-based therapies in advanced lung cancer
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113809openalex-snapshot
The impact of neoadjuvant immunotherapy on the clinical efficacy of stage IIIA-N2 non-small cell lung cancer patients
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115161openalex-snapshot
Hypoxia-induced tumor cell-intrinsic PLAU activation drives immunotherapy resistance in collagenic lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115305openalex-snapshot
ABCA4 regulates mitophagy in lung adenocarcinoma progression via AMPK pathway by modulating TMSB4X
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.116037openalex-snapshot
Study on the mechanism of PSENEN in modulating cisplatin resistance in NSCLC through stromal cell interactions
inferred← citeshttps://doi.org/10.1016/j.intimp.2026.116325openalex-snapshot
PARP inhibitor combined with platinum activates the cGAS-STING pathway to enhance anti-PD-L1 immunotherapy in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.intimp.2026.116481openalex-snapshot
Efficacy and safety of a low-dose nivolumab regimen (240 mg) as neoadjuvant immunochemotherapy in Chinese patients with resectable non-small cell lung cancer: a prospective single-arm, exploratory study
inferred← citeshttps://doi.org/10.1016/j.isci.2024.110832openalex-snapshot
CircPOLA2 sensitizes non-small cell lung cancer cells to ferroptosis and suppresses tumorigenesis via the Merlin-YAP signaling pathway
inferred← citeshttps://doi.org/10.1016/j.isci.2025.112615openalex-snapshot
Complex regulatory network of programmed death-ligand 1 in cancer: Cancer immunomodulation from molecular mechanisms to clinical applications
inferred← citeshttps://doi.org/10.1016/j.isci.2026.117336openalex-snapshot
Integrating proteomics and metabolomics to reveal MAT2A for metabolic reprogramming in non-small cell lung cancer cells
inferred← citeshttps://doi.org/10.1016/j.jare.2025.12.049openalex-snapshot
Tryptophan metabolism in tumor microenvironment and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.113644openalex-snapshot
Inhalable pH-responsive charge-reversal polymer-small interfering RNA polyplexes for directed gene therapy of anaplastic lymphoma kinase fusion-positive lung cancer
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114345openalex-snapshot
Hybrid nanovesicles enhance antitumor efficacy in KRAS-mutant non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114519openalex-snapshot
Pulmonary macrophage-targeted RNAi and mRNA co-delivery via SORT lipid nanoparticles enhances immunotherapy in lung cancer
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104346openalex-snapshot
PLGA-PEI nanobubbles carrying PDLIM5 siRNA inhibit EGFR-TKI-resistant NSCLC cell migration and invasion ability using UTND technology
inferred← citeshttps://doi.org/10.1016/j.jep.2023.116948openalex-snapshot
Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway
inferred← citeshttps://doi.org/10.1016/j.jff.2025.106729openalex-snapshot
Targeting acquired resistance via promoting stemness of EGFR mutant mitigates lung adenocarcinomas progression: Intervention by harpagoside (Xuandanqingjin decoction)
inferred← citeshttps://doi.org/10.1016/j.jhep.2025.07.016openalex-snapshot
Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.jpha.2024.03.002openalex-snapshot
β-elemene promotes miR-127-3p maturation, induces NSCLCs autophagy, and enhances macrophage M1 polarization through exosomal communication
inferred← citeshttps://doi.org/10.1016/j.jpha.2024.101154openalex-snapshot
PU.1 regulation of type 1 dendritic cell function via NF-κB pathway in inhibition of non-small cell lung cancer progression
inferred← citeshttps://doi.org/10.1016/j.jpsychores.2023.111374openalex-snapshot
Factors influencing the preoperative anxiety in lung cancer patients undergoing video-assisted thoracoscopic surgery: The role of information needs, illness perception and patient trust
inferred← citeshttps://doi.org/10.1016/j.jrras.2025.102154openalex-snapshot
LRG1 protein is a novel prognostic indicator for patients with non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.jtho.2024.01.013openalex-snapshot
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)
inferred← citeshttps://doi.org/10.1016/j.jtho.2025.02.003openalex-snapshot
Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC: A Phase 1 Dose-Escalation and Dose-Expansion Study
inferred← citeshttps://doi.org/10.1016/j.jval.2026.07.002openalex-snapshot
Health-Related Quality of Life and Utility Values in Chinese Patients With Non-Small Cell Lung Cancer: A Multicenter Study
inferred← citeshttps://doi.org/10.1016/j.jvir.2024.10.008openalex-snapshot
Outcomes of First-Line Microwave Ablation of Treatment-Naive Epidermal Growth Factor Receptor–Mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors
inferred← citeshttps://doi.org/10.1016/j.lddd.2025.100097openalex-snapshot
Uncovering the mechanism of ARRDC3 in non-small cell lung cancer cisplatin resistance and autophagy based on bioinformatics and experimental verification
inferred← citeshttps://doi.org/10.1016/j.lfs.2023.122033openalex-snapshot
Regulation of cytokinesis and necroptosis pathways by diosgenin inhibits the proliferation of NCI-H460 lung cancer cells
inferred← citeshttps://doi.org/10.1016/j.lfs.2025.123599openalex-snapshot
The crosstalk between lung adenocarcinoma cells and M2 macrophages promotes cancer cell development via the SFRS1/miR-708-5p/PD-L1 axis
inferred← citeshttps://doi.org/10.1016/j.lungcan.2024.107817openalex-snapshot
The significance of inflammatory markers in prognosticating the effectiveness and safety of immunotherapy in conjunction with chemotherapy during the primary intervention of advanced non-small cell lung carcinoma
inferred← citeshttps://doi.org/10.1016/j.lungcan.2025.108508openalex-snapshot
Associations between carbohydrate quality and the survival of, and life expectancy with lung cancer patient: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.lungcan.2026.109343openalex-snapshot
Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort
showing the first 199 of 654 · page through all 654
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.